+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiovascular and Soft Tissue Repair Patches Market Size, Share & Trends Analysis Report by Application (Cardiac, Soft Tissue), By Raw Material (ePTFE, Biomaterial), And Segment Forecasts, 2019 - 2025

  • ID: 4764585
  • Report
  • April 2019
  • Region: Global
  • 125 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott (St Jude Medical)
  • Atriummed
  • Baxter
  • Cryolife, Inc.
  • Gunze Limited
  • LeMaitre Vascular Inc.
  • MORE
The global cardiovascular and soft tissue repair patches market size is expected to reach USD 5.71 billion by 2025, at a CAGR 8.2 % over a forecast period. Increasing application of these patches in medical procedures and sports injuries and rising prevalence of heart defects such as atrial septal defect and ventricular septal defect are some of the factors driving the demand.

Growing prevalence of Cardiovascular Diseases (CVDs) is one of the key market drivers. According to the American Heart Association, cardiovascular diseases accounted for nearly 800,000 deaths in the U.S. in 2017. Moreover, the prevalence of heart attacks is significantly high in the country. Nearly, 790,000 U.S. adults suffer from heart attack each year. Coronary heart diseases account for the majority of CVD deaths followed by heart attack and stroke. High prevalence of such diseases is anticipated to create lucrative growth opportunities for the market.

Growing prevalence of hernia is also one of the key market drivers. Key risk factors for hernia are abdominal surgery, heavy weight lifting, chronic cough, constipation, ascites (fluid in abdomen), and other conditions that increase pressure on the intra-abdominal region. Furthermore, nerve damage, loss of tissue strength, and genetic factors lead to weakening of muscles. Congenital hernia is due to residual embryological channel defect and family history. According to a survey, in 2016, around 20 million repairs of inguinal hernia were carried out each year across the globe. Thus, the demand for these patches in healing the wounds post operation is anticipated to grow significantly over the years.

Further key findings from the report suggest:
  • In 2018, soft tissue repair held the largest market share in terms of revenue owing to the increasing prevalence of hernia
  • Cardiac repair segment is expected to witness rapid growth over the forecast period owing to high prevalence of congenital heart diseases coupled with improving treatments globally
  • ePTFE segment accounted for the largest revenue share of raw materials in 2018 however biomaterial and tissue engineered materials segment is expected to register the fastest CAGR over the forecast period
  • In 2018, North America held the largest revenue share due to high prevalence of diseases and easy access of treatment alternatives
  • Asia Pacific is expected to emerge at the fastest CAGR over the forecast period owing to growing prevalence of congenital heart diseases and hernia
  • Key players operating in the cardiovascular and soft tissue repair patches market include Edwards Life Sciences; Cryolife; Baxter; Bard Peripheral Vascular Inc.; and W.L.Gore & Associates.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott (St Jude Medical)
  • Atriummed
  • Baxter
  • Cryolife, Inc.
  • Gunze Limited
  • LeMaitre Vascular Inc.
  • MORE
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Cardiovascular and Soft Tissue Repair Patches Market Variables, Trends & Scope
3.1 Cardiovascular and soft tissue repair patches Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer behaviour analysis
3.4.2 Market influencer analysis
3.5 Procedure Cost Analysis/Breakdown
3.6 List of Key End-users
3.7 Technology Overview
3.7.1 Technology timeline
3.8 Regulatory Framework
3.8.1 Reimbursement framework
3.8.2 Standards and compliances
3.9 Cardiovascular and soft tissue repair patches Market Dynamics
3.9.1 Market driver analysis
3.9.2 Market restraint analysis
3.9.3 Industry challenges
3.10 Cardiovascular and Soft Tissue Repair Patches Market Analysis Tools
3.10.1 Industry analysis – Porter’s
3.10.1.1 Supplier power
3.10.1.2 Buyer power
3.10.1.3 Substitution threat
3.10.1.4 Threats from new entrant
3.10.1.5 Competitive rivalry
3.10.2 PESTEL analysis
3.10.2.1 Political landscape
3.10.2.2 Enviornmental landscape
3.10.2.3 Social landscape
3.10.2.4 Technology landscape
3.10.2.5 Economic landscape
3.10.2.6 Legal landscape
3.10.3 Major deals & strategic alliances analysis
3.10.3.1 Joint Ventures
3.10.3.2 Mergers & Acquisitions
3.10.3.3 Licensing & Partnership
3.10.4 Market entry strategies

Chapter 4 Cardiovascular and Soft Tissue Repair Patches Market- Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company ranking, by region
4.5 Private Companies
4.5.1 List of key emerging companies /technology disruptors/innovators
4.5.2 Regional network map
4.5.3 Company market position analysis

Chapter 5 Cardiovascular and soft Tissue Repair Patches Market: Application Estimates & Trend Analysis
5.1 Definition & Scope
5.2 Application Market Share Analysis, 2018 & 2025
5.3 Segment Dashboard
5.4 Global Cardiovascular and soft Tissue Repair Patches Market Revenue Estimates and Forecasts, by Application, 2014 - 2025 (USD Million)
5.4.1 Cardiac repair
5.4.1.1 Market revenue estimates and forecasts for cardiac repair, 2014 - 2025 (USD Million)
5.4.1.2 Atrial septal defect
5.4.1.2.1 Market revenue estimates and forecasts for atrial septal defect, 2014 - 2025 (USD Million)
5.4.1.3 Common atrium
5.4.1.3.1 Market revenue estimates and forecasts for common atrium, 2014 - 2025 (USD Million)
5.4.1.4 Defects of the endocardial cushion
5.4.1.4.1 Market revenue estimates and forecasts for defects of the endocardial cushion, 2014 - 2025 (USD Million)
5.4.1.5 Ventricular septal defect
5.4.1.5.1 Market revenue estimates and forecasts for ventricular septal defect, 2014 - 2025 (USD Million)
5.4.1.6 Tetralogy of Fallot
5.4.1.6.1 Market revenue estimates and forecasts tetralogy of Fallot, 2014 - 2025 (USD Million)
5.4.1.7 Right Ventricular Outflow Tract Reconstruction
5.4.1.7.1 Market revenue estimates and forecasts for right ventricular outflow tract reconstruction, 2014 - 2025 (USD Million)
5.4.1.8 Suture bleeding
5.4.1.8.1 Market revenue estimates and forecasts for suture bleeding, 2014 - 2025 (USD Million)
5.4.1.9 Market revenue estimates and forecasts for cardiac repair, by raw materials, 2014 - 2025 (USD Million)
5.4.2 Vascular repair and reconstruction
5.4.2.1 Market revenue estimates and forecasts for vascular repair and reconstruction, 2014 - 2025 (USD Million)
5.4.2.2 Carotid endarterectomy
5.4.2.2.1 Market revenue estimates and forecasts for carotid endarterectomy, 2014 - 2025 (USD Million)
5.4.2.3. Anomalous connection of the pulmonary veins
5.4.2.3.1 Market revenue estimates and forecasts for anomalous connection of the pulmonary veins, 2014 - 2025 (USD Million)
5.4.2.4 Transposition of the great vessels
5.4.2.4.1 Market revenue estimates and forecasts for transposition of the great vessels, 2014 - 2025 (USD Million)
5.4.2.5 Reconstruction of portal and superior mesenteric veins
5.4.2.5.1 Market revenue estimates and forecasts for reconstruction of portal and superior mesenteric veins, 2014 - 2025 (USD Million)
5.4.2.6 Other vascular repair and reconstruction
5.4.2.6.1 Market revenue estimates and forecasts for other vascular repair and reconstruction, 2014 - 2025 (USD Million)
5.4.2.7 Market revenue estimates and forecasts for vascular repair and reconstruction, by raw materials, 2014 - 2025 (USD Million)
5.4.3 Pericardial repair
5.4.3.1 Market revenue estimates and forecasts for pericardial repair, 2014 - 2025 (USD Million)
5.4.3.2 Market revenue estimates and forecasts pericardial repair, by raw materials, 2014 - 2025 (USD Million)
5.4.4 Dural repair
5.4.4.1 Dural repair market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.4.2 Market revenue estimates and forecasts for dural repair, by raw materials, 2014 - 2025 (USD Million)
5.4.5 Soft tissue repair
5.4.5.1 Soft tissue repair market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.5.2 Defects of abdominal wall
5.4.5.2.1 Market revenue estimates and forecasts for defects of abdominal wall, 2014 - 2025 (USD Million)
5.4.5.3 Defects of thoracic wall
5.4.5.3.1 Market revenue estimates and forecasts for defects of abdominal wall, 2014 - 2025 (USD Million)
5.4.5.4 Gastric binding
5.4.5.4.1 Market revenue estimates and forecasts for gastric binding, 2014 - 2025 (USD Million)
5.4.5.5 Hernias
5.4.5.5.1 Market revenue estimates and forecasts for Hernias, 2014 - 2025 (USD Million)
5.4.5.6 Market revenue estimates and forecasts for soft tissue repair, by raw materials, 2014 - 2025 (USD Million)

Chapter 6 Cardiovascular and Soft Tissue Repair Patches Market: Raw Materials Estimates & Trend Analysis
6.1 Definition & Scope
6.2 Raw Materials Market Share Analysis, 2018 & 2025
6.3 Segment Dashboard
6.4 Global Cardiovascular and soft Tissue Repair Patches Market Revenue Estimates and Forecasts, by Raw Materials, 2014 - 2025 ( USD Million)
6.4.1 ePTFE
6.4.1.1 ePTFE based patches market revenue estimates and forecasts, 2014 - 2025 (USD Million)
6.4.2 Biomaterial and tissue engineered materials
6.4.2.1 Biomaterial and tissue engineered material based patches market revenue estimates and forecasts, 2014 - 2025 (USD Million)
6.4.3 Other raw materials
6.4.3.1 Other raw material based patches market revenue estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 7 Cardiovascular and soft tissue repair patches Market: Regional Estimates & Trend Analysis, By Application and By Raw Materials
7.1 Regional Cardiovascular and Soft Tissue Repair Patches Market Snapshot, (Market size, CAGR, top verticals, top trends)
7.2 List of Key Players, by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 MEA
7.3 North America
7.3.1 North America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.3.2 North America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.3.3. U.S.
7.3.3.1 U.S. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.3.3.2 U.S. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.3.4 Canada
7.3.4.1 Canada cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.3.4.2 Canada cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4 Europe
7.4.1 Europe cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.2 Europe cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4.3. U.K.
7.4.3.1 U.K. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.3.2 U.K. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4.4 Germany
7.4.4.1 Germany cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.4.2 Germany cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4.5. France
7.4.5.1 France cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.5.2 France cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4.6 Spain
7.4.6.1 Spain cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.6.2 Spain cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4.7. Italy
7.4.7.1 Italy cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.7.2 Italy cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.4.8 Russia
7.4.8.1 Russia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.8.2 Russia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.2 Asia Pacific cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5.3. Japan
7.5.3.1 Japan cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.3.2 Japan cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5.4 China
7.5.4.1 China cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.4.2 China cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5.5. India
7.5.5.1 India cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.5.2 India cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5.6 Australia
7.5.6.1 Australia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.6.2 Australia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5.7. Singapore
7.5.7.1 Singapore cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.7.2 Singapore cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.5.8 South Korea
7.5.8.1 South Korea cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.8.2 South Korea cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.6 Latin America
7.6.1 Latin America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.2 Latin America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.6.3. Brazil
7.6.3.1 Brazil cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.3.2 Brazil cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.6.4 Mexico
7.6.4.1 Mexico cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.4.2 Mexico cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.6.5. Argentina
7.6.5.1 Argentina cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.5.2 Argentina cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.7 MEA
7.7.1 MEA cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.7.2 MEA cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.7.3. South Africa
7.7.3.1 South Africa cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.7.3.2 South Africa cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.7.4 Saudi Arabia
7.7.4.1 Saudi Arabia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.7.4.2 Saudi Arabia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.7.5. UAE
7.7.5.1 UAE cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.7.5.2 UAE cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2014 - 2025 (USD Million)
7.8 SWOT Analysis, by Factor
7.8.1 North America
7.8.2 Europe
7.8.3 Asia Pacific
7.8.4 Latin America
7.8.5 Middle East & Africa

Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Baxter
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 Admedus
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Abbott (St Jude Medical)
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 LeMaitre Vascular Inc.
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 Edwards Life Sciences Corporation
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Glycar SA Pty Ltd.
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 LabCor
8.1.9.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 Cryolife, Inc.
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 CorMatrix
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 Terumo Medical Corporation
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
8.1.10.4 Strategic Initiatives
8.1.11 Bard Peripheral Vascular Inc.
8.1.11.1 Company Overview
8.1.11.2 Financial Performance
8.1.11.3 Product Benchmarking
8.1.11.4 Strategic Initiatives
8.1.12 Neovasc
8.1.12.1 Company Overview
8.1.12.2 Financial Performance
8.1.12.3 Product Benchmarking
8.1.12.4 Strategic Initiatives
8.1.13 W.L. Gore & Associates, Inc.
8.1.13.1 Company Overview
8.1.13.2 Financial Performance
8.1.13.3 Product Benchmarking
8.1.13.4 Strategic Initiatives
8.1.14 B.Braun
8.1.14.1 Company Overview
8.1.14.2 Financial Performance
8.1.14.3 Product Benchmarking
8.1.14.4 Strategic Initiatives
8.1.15 Novomedics
8.1.15.1 Company Overview
8.1.15.2 Financial Performance
8.1.15.3 Product Benchmarking
8.1.15.4 Strategic Initiatives
8.1.16 TEI Biosciences Inc.
8.1.16.1 Company Overview
8.1.16.2 Financial Performance
8.1.16.3 Product Benchmarking
8.1.16.4 Strategic Initiatives
8.1.17 Perouse Medical
8.1.17.1 Company Overview
8.1.17.2 Financial Performance
8.1.17.3 Product Benchmarking
8.1.17.4 Strategic Initiatives
8.1.18 Gunze Limited
8.1.18.1 Company Overview
8.1.18.2 Financial Performance
8.1.18.3 Product Benchmarking
8.1.18.4 Strategic Initiatives
8.1.19 Atriummed
8.1.19.1 Company Overview
8.1.19.2 Financial Performance
8.1.19.3 Product Benchmarking
8.1.19.4 Strategic Initiatives
8.1.20 Maverick Bioscience
8.1.20.1 Company Overview
8.1.20.2 Financial Performance
8.1.20.3 Product Benchmarking
8.1.20.4 Strategic Initiatives
8.1.21 Southern Lights Biomaterials
8.1.21.1 Company Overview
8.1.21.2 Financial Performance
8.1.21.3 Product Benchmarking
8.1.21.4 Strategic Initiatives
8.2 List of Other Companies

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4
  • Baxter
  • Admedus
  • Abbott (St Jude Medical)
  • LeMaitre Vascular Inc.
  • Edwards Life Sciences Corporation
  • Glycar SA Pty Ltd.
  • LabCor
  • Cryolife, Inc.
  • CorMatrix
  • Terumo Medical Corporation
  • Bard Peripheral Vascular Inc.
  • Neovasc
  • W.L. Gore & Associates, Inc.
  • B.Braun
  • Novomedics
  • TEI Biosciences Inc.
  • Perouse Medical
  • Gunze Limited
  • Atriummed
  • Maverick Bioscience
  • Southern Lights Biomaterials
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll